Exeliom Biosciences announces three phase II clinical trials in immuno-oncology with lead candidate pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
CE-Ventures leads the final close of the $26mln Series A funding round for Exeliom Biosciences to advance pipeline-in-a-drug strategy zawya.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from zawya.com Daily Mail and Mail on Sunday newspapers.
PARIS & DIJON, FRANCE, March 21, 2023 (Newswire.com) - Exeliom Biosciences, a biotechnology company, announced today the enrollment of the first patient in its Phase 1 clinical study of an investigational oral single-strain microbiome therapeutic (EXL-01) developed to.